“Adidas AG, Under Armour Inc. and MapMyFitness Inc. have resolved their pending patent litigation and entered into a confidential settlement agreement,” a spokesperson for Adidas said in an email statement to Footwear News on Thursday. “The parties were able to reach a mutually acceptable settlement agreement in which Adidas’s claims against Under Armour and its subsidiary MapMyFitness were dismissed with prejudice and Adidas granted a license to its patents in suit in exchange for a confidential licensing fee payable by Under Armour and MapMyFitness.”
In 2014, shortly after Under Armour acquired fitness technology platform MapMyFitness, Adidas filed a suit in the U.S. District Court for the District of Delaware alleging that several of the company’s fitness training and tracker devices infringed on its patents.
Among its claims, the Germany-based company said it “had been and continues to be injured” by Under Armour and MapMyFitness’ alleged infringement of its patents and, as such, “Adidas is entitled to recover damages adequate to compensate it.”
Claiming the patents in Adidas’ suit were never patentable to begin with, in November 2015, Under Armour filed a petition with the U.S. Patent and Trademark Office (USPTO) for inter partes review, a trial proceeding to review the patentability of a previously filed and granted patent.
On May 6, Under Armour and Adidas filed a joint motion to terminate the case in the USPTO while Adidas’ civil suit was dismissed in the Delaware court on May 4.